ReviewAntioxidants (Basel, Switzerland)2023

A Preclinical Model for Parkinson's Disease Based on Transcriptional Gene Activation via KEAP1/NRF2 to Develop New Antioxidant Therapies.

Juan Segura-Aguilar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.